Mark Vignola, based in New York, NY, US, is currently a Chief Financial Officer at Terns Pharmaceuticals, bringing experience from previous roles at Reference Home Theater, Applied Therapeutics and Intercept Pharmaceuticals. Mark Vignola holds a 2003 - 2009 PhD in Molecular Genetics and Microbiology @ Duke University Graduate School. With a robust skill set that includes Biochemistry, Cell, Molecular Biology, Biotechnology, Cell Biology and more, Mark Vignola contributes valuable insights to the industry. Mark Vignola has 5 emails and 1 mobile phone number on RocketReach.